USRM (US Stem Cell) Days Payable: 29,145.25 (As of Dec. 2022)


USRM US Stem Cell Inc USRM
12 GF Score
Price $0.00
View Full Analysis

What is US Stem Cell Days Payable?

US Stem Cell USRM -99.00% 12 Days Payable is 29,145.25 as of Dec. 2022. GuruFocus rates USRM with a GF Score™ of 12/100.

US Stem Cell's average Accounts Payable for the three months ended in Dec. 2022 was $1.60 Mil. US Stem Cell's Cost of Goods Sold for the three months ended in Dec. 2022 was $0.01 Mil. Hence, US Stem Cell's Days Payable for the three months ended in Dec. 2022 was 29,145.25.

The historical rank and industry rank for US Stem Cell's Days Payable or its related term are showing as below:

USRM's Days Payable is not ranked *
in the Biotechnology industry.
Industry Median: 113.76
* Ranked among companies with meaningful Days Payable only.

US Stem Cell's Days Payable increased from Dec. 2021 (13,363.06) to Dec. 2022 (29,145.25). It may suggest that US Stem Cell delayed paying its suppliers.

US Stem Cell Days Payable Historical Data

* Premium members only.

The historical data trend for US Stem Cell's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

US Stem Cell Days Payable Chart

US Stem Cell Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 221.40 324.13 7,043.36 9,318.03 22,797.29

US Stem Cell Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13,363.06 18,804.02 19,716.52 28,123.25 29,145.25

USRM vs NOVNQ, RGRX, NMTRQ: Days Payable Comparison

For the Biotechnology subindustry, US Stem Cell's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

US Stem Cell Days Payable vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, US Stem Cell's Days Payable distribution charts can be found below:

* The bar in red indicates where US Stem Cell's Days Payable falls into.


USRM
12GF Score
US Stem Cell Inc USRM
Days Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

US Stem Cell Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

US Stem Cell's Days Payable for the fiscal year that ended in Dec. 2022 is calculated as

Days Payable (A: Dec. 2022 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2021 ) + Accounts Payable (A: Dec. 2022 )) / count ) / Cost of Goods Sold (A: Dec. 2022 )*Days in Period
=( (1.373 + 1.625) / 2 ) / 0.024*365
=1.499 / 0.024*365
=22,797.29

US Stem Cell's Days Payable for the quarter that ended in Dec. 2022 is calculated as:

Days Payable (Q: Dec. 2022 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Sep. 2022 ) + Accounts Payable (Q: Dec. 2022 )) / count ) / Cost of Goods Sold (Q: Dec. 2022 )*Days in Period
=( (1.569 + 1.625) / 2 ) / 0.005*365 / 4
=1.597 / 0.005*365 / 4
=29,145.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 29,145.25 mean?
US Stem Cell (USRM) has a Days Payable of 29,145.25 as of Dec. 2022. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on US Stem Cell and its competitors.
Is US Stem Cell's Days Payable too high?
US Stem Cell's current Days Payable is 29,145.25. The Biotechnology industry median Days Payable is 113.76. US Stem Cell's value of 29,145.25 is 25519.9% above this industry median. Overall, US Stem Cell has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does US Stem Cell's Days Payable compare to NOVNQ and RGRX?
US Stem Cell's Days Payable of 29,145.25 can be compared against companies in the Biotechnology industry. The industry median Days Payable is 113.76. US Stem Cell's value of 29,145.25 is 25519.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.76, based on 707 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. US Stem Cell's current Days Payable of 29,145.25 is 25519.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on US Stem Cell and its competitors. For the Biotechnology industry, the median Days Payable is 113.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. US Stem Cell's current Days Payable is 29,145.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is US Stem Cell stock overvalued right now?
US Stem Cell (USRM) has a current Days Payable of 29,145.25. The current Days Payable is 29,145.25 and 25519.9% above the Biotechnology industry median of 113.76. US Stem Cell's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For US Stem Cell (USRM), the current Days Payable is 29,145.25 as of Dec. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

US Stem Cell Business Description

Address 1560 Sawgrass Corporate Parkway, 4th Floor, Sunrise, FL, USA, 33323
US Stem Cell Inc is a biotechnology company engaged in the discovery and development of autologous cell therapies for the treatment of chronic and acute heart damage. Its product includes MyoCell, a clinical therapy designed to populate regions of scar tissue within a patient's heart with autologous muscle cells, or cells from a patient's body, for the purpose of improving cardiac function in chronic heart failure patients. The company's discoveries include multiple cell therapies in various stages of development that repair damaged tissues throughout the body due to injury or disease so that patients may return to a normal lifestyle.
12GF Score

Get the complete analysis for USRM

Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price